Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 3,000 peer-reviewed publications. The CPRD bibliography listed below is updated on a monthly basis (last updated 4 March 2024).

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: CPRD bibliography PDF March 2024 (PDF, 4.2MB, 313 pages) 

Download: CPRD bibliography .BIB March 2024 (BIB, 1.3MB, 1 page)

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

Page last reviewed
Year Sort ascending Title
2022

Epidemiology of prurigo nodularis in England: a retrospective database analysis

10.1111/bjd.21032

Authors: C. Morgan, M. Thomas, S. Ständer, Z. Jabbar-Lopez, C. Piketty, S. Gabriel, C. Currie, J. Puelles

2022

Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study

10.1186/s12933-021-01432-1

Authors: Charlier SH, C. Meier, S. Jick, C. Meier, C. Becker

2022

First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

10.1007/s41030-021-00179-0

Authors: C. Bloom, J. Montonen, O. Jöns, E. Garry, S. Bhatt

2022

β-Blockers and the Risk of Depression: A Matched Case-Control Study

10.1007/s40264-021-01140-5

Authors: D. Bornand, D. Reinau, S. Jick, C. Meier

2022

Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis

10.1186/s12890-022-01823-4

Authors: A. Gayle, C. Minelli, J. Quint

2022

Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England

10.2147/jaa.s335960

Authors: A. Bhavsar, E. Aris, L. Harrington, J. Simeone, A. Ramond, D. Lambrelli, A. Papi, L. Boulet, K. Meszaros, N. Jamet, Y. Sergerie, P. Mukherjee

2022

Alcohol use recording in adults with depression in English primary care: a cross-sectional study

10.1136/bmjopen-2021-055975

Authors: E. Adesanya, S. Cook, E. Crellin, S. Langan, K. Mansfield, L. Smeeth, E. Herrett

2022

Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom's CPRD 1995-2015

10.2147/clep.s341048

Authors: O. Ayodele, H. Cabral, D. McManus, S. Jick

2022

Treatment Transitions in Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases

10.1007/s41030-021-00180-7

Authors: C. Bloom, J. Montonen, O. Jöns, E. Garry, S. Bhatt

2022

The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care

10.1016/s2666-7568(21)00281-6

Authors: E. Herrett, H. Strongman, S. Gadd, L. Tomlinson, D. Nitsch, K. Bhaskaran, E. Williamson, T. Van Staa, R. Sofat, A. Timmis, S. Wells, L. Smeeth, R. Jackson

2022

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

10.1371/journal.pmed.1003870

Authors: H. Strongman, H. Carreira, B. De Stavola, K. Bhaskaran, D. Leon

2022

Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study

10.1016/j.joca.2021.12.013

Authors: S. Swain, C. Coupland, V. Strauss, C. Mallen, C. Kuo, A. Sarmanova, S. Bierma-Zeinstra, M. Englund, D. Prieto-Alhambra, M. Doherty, W. Zhang

2022

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population

10.1183/23120541.00606-2021

Authors: H. Ashdown, M. Smith, E. McFadden, I. Pavord, C. Butler, M. Bafadhel

2022

Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021

10.1136/annrheumdis-2021-221989

Authors: A. Abhishek, L. Tata, M. Mamas, A. Avery

2022

Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study

10.1186/s12884-022-04442-3

Authors: S. Lee, A. Azcoaga-Lorenzo, U. Agrawal, J. Kennedy, A. Fagbamigbe, H. Hope, A. Subramanian, A. Anand, B. Taylor, C. Nelson-Piercy, C. Damase-Michel, C. Yau, F. Crowe, G. Santorelli, K. Eastwood, Z. Vowles, M. Loane, N. Moss, P. Brocklehurst, R. Plachcinski, S. Thangaratinam, M. Black, D. O'Reilly, K. Abel, S. Brophy, K. Nirantharakumar, C. McCowan

2022

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink

10.2217/cer-2021-0305

Authors: C. Foch, A. Allignol, T. Hohenberger, E. Boutmy, S. Schaefer, U. Hostalek

2022

Continuity of GP care for patients with dementia: impact on prescribing and the health of patients

10.3399/bjgp.2021.0413

Authors: J. Delgado, P. Evans, D. Gray, K. Sidaway-Lee, L. Allan, L. Clare, C. Ballard, J. Masoli, J. Valderas, D. Melzer

2022

The feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark and England

10.1038/s41541-022-00444-6

Authors: J. Nealon, D. Modin, R. Ghosh, D. Rudin, G. Gislason, H. Booth, J. Jensen, R. Williams, H. Shepherd, E. Yelland, H. Bricout, S. Chaves, T. Biering-Sørensen

2022

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes

10.2337/dc21-1953

Authors: R. Pradhan, H. Yin, O. Yu, L. Azoulay

2022

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study

10.1093/aje/kwac021

Authors: R. Pradhan, E. Patorno, H. Tesfaye, S. Schneeweiss, H. Yin, J. Franklin, A. Pawar, C. Santella, O. H. Y. Yu, C. Renoux, L. Azoulay

2022

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

10.1093/eurheartj/ehac056

Authors: S. Hageman, A. McKay, P. Ueda, L. Gunn, T. Jernberg, E. Hagström, D. Bhatt, P. Steg, K. Läll, R. Mägi, Nordbø Gynnild, H. Ellekjær, I. Saltvedt, J. Tuñón, I. Mahíllo, Á Aceña, K. Kaminski, M. Chlabicz, E. Sawicka, T. Tillman, J. McEvoy, E. Di Angelantonio, I. Graham, D. De Bacquer, K. Ray, J. Dorresteijn, F. Visseren

2022

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

10.1007/s00198-021-06262-1

Authors: S. Khalid, S. Calderon-Larranaga, A. Sami, S. Hawley, A. Judge, N. Arden, T. van Staa, C. Cooper, B. Abrahamsen, M. Javaid, D. Prieto-Alhambra

2022

Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England

10.1186/s12933-021-01435-y

Authors: S. Abner, C. Gillies, S. Shabnam, F. Zaccardi, S. Seidu, M. Davies, T. Adeyemi, K. Khunti, D. Webb

2022

Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting

10.1002/pds.5412

Authors: J. Tazare, R. Wyss, J. Franklin, L. Smeeth, S. Evans, S. Wang, S. Schneeweiss, I. Douglas, J. Gagne, E. Williamson

2022

Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data

10.1136/bmjopen-2021-055603

Authors: C. Clarke, E. Williamson, S. Denaxas, J. Carpenter, M. Thomas, H. Blackshaw, A. Schilder, C. Philpott, C. Hopkins, S. Morris

2022

Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis

10.1002/acr.24866

Authors: G. Ozen, S. Dell'Aniello, S. Pedro, K. Michaud, S. Suissa

2022

Surgical treatment, complications, reoperations, and healthcare costs among patients with clavicle fracture in England

10.1186/s12891-022-05075-5

Authors: S. Wolf, A. Chitnis, A. Manoranjith, M. Vanderkarr, J. Plaza, L. Gador, C. Holy, C. Sparks, S. Lambert

2022

The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records

10.1186/s12916-022-02247-x

Authors: R. Joseph, R. Jack, R. Morriss, R. Knaggs, D. Butler, C. Hollis, J. Hippisley-Cox, C. Coupland

2022

Primary care clinical management following self-harm during the first wave of COVID-19 in the UK: population-based cohort study

10.1136/bmjopen-2021-052613

Authors: S. Steeg, M. Carr, L. Trefan, D. Ashcroft, N. Kapur, E. Nielsen, B. McMillan, R. Webb

2022

No evidence that herpes zoster is associated with increased risk of dementia diagnosis

10.1002/acn3.51525

Authors: C. Warren-Gash, E. Williamson, S. Shiekh, J. Borjas-Howard, N. Pearce, J. Breuer, L. Smeeth

2022

Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom

10.1016/j.diabres.2022.109229

Authors: R. Pradhan, O. Yu, R. Platt, L. Azoulay

2022

Investigating the optimal handling of uncertain pregnancy episodes in the CPRD GOLD Pregnancy Register: a methodological study using UK primary care data

10.1136/bmjopen-2021-055773

Authors: J. Campbell, K. Bhaskaran, S. Thomas, R. Williams, H. McDonald, C. Minassian

2022

Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink

10.1080/03007995.2022.2029381

Authors: C. Tran, M. Bøg, S. Collings, M. Johnson, N. Qizilbash, S. Lind, R. Baker, K. Jørgensen

2022

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

10.1136/bmjdrc-2021-002517

Authors: T. Weiss, L. Yang, R. Carr, S. Pal, B. Sawhney, R. Boggs, S. Rajpathak, K. Iglay

2022

Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes

10.2337/dc21-1113

Authors: A. Wright, M. Carr, E. Kontopantelis, L. Leelarathna, H. Thabit, R. Emsley, I. Buchan, M. Mamas, T. van Staa, N. Sattar, D. Ashcroft, M. Rutter

2022

Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study

10.14283/jpad.2022.8

Authors: B. Zheng, B. Su, C. Udeh-Momoh, G. Price, I. Tzoulaki, E. Vamos, A. Majeed, E. Riboli, S. Ahmadi-Abhari, L. Middleton

2021

Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities

10.1016/j.jaip.2021.07.056

Authors: M. Kerkhof, T. Tran, R. Allehebi, G. Canonica, L. Heaney, M. Hew, Perez de Llano, M. Wechsler, L. Bulathsinhala, V. Carter, I. Chaudhry, N. Eleangovan, R. Murray, C. Price, D. Price

2021

Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety

10.1016/j.rmed.2021.106645

Authors: S. Suissa, S. Dell'Aniello, P. Ernst

2021

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort

10.1001/jamanetworkopen.2021.5329

Authors: C. Dormuth, B. Winquist, A. Fisher, F. Wu, P. Reynier, S. Suissa, M. Dahl, Z. Ma, X. Lu, J. Zhang, C. Raymond, K. Filion, R. Platt, C. Moriello, J. Paterson

2021

The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom

10.1002/iid3.495

Authors: G. Requena, J. Logie, D. Gibbons, J. Steinfeld, M. Van Dyke

2021

Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes

10.1002/cpt.2430

Authors: J. Faillie, H. Yin, O. H. Y. Yu, A. Herrero, R. Altwegg, C. Renoux, L. Azoulay

2021

Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

10.1016/s2589-7500(21)00017-0

Authors: K. Mansfield, R. Mathur, J. Tazare, A. Henderson, A. Mulick, H. Carreira, A. Matthews, P. Bidulka, A. Gayle, H. Forbes, S. Cook, A. Wong, H. Strongman, K. Wing, C. Warren-Gash, S. Cadogan, L. Smeeth, J. Hayes, J. Quint, M. McKee, S. Langan

2021

Inequalities in incident and prevalent multimorbidity in England, 2004\textendash19: a population-based, descriptive study

10.1016/S2666-7568(21)00146-X

Authors: A. Head, K. Fleming, C. Kypridemos, P. Schofield, J. Pearson-Stuttard, M. O\textquoterightFlaherty

2021

Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020

10.1136/bmjopen-2021-053427

Authors: C. Lee, F. Waite, M. Smith, M. Gao, C. Bankhead, P. Aveyard, C. Piernas

2021

wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study

10.1136/bmjopen-2021-055219

Authors: B. Torlinska, J. Hazlehurst, K. Nirantharakumar, G. Thomas, J. Priestley, S. Finnikin, P. Saunders, K. Abrams, K. Boelaert

2021

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

10.1038/s41366-021-00788-4

Authors: C. Haase, S. Lopes, A. Olsen, A. Satylganova, V. Schnecke, P. McEwan

2021

What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

10.1093/rheumatology/keab254

Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, W. Zhang, M. Doherty, M. Taal, G. Aithal, A. Abhishek

2021

Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study

10.1210/clinem/dgab392

Authors: T. Berni, C. Morgan, D. Rees

2021

Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study

10.1007/s00198-021-05862-1

Authors: J. Erwin, D. Enki, A. Woolf

2021

β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study

10.1093/rheumatology/keab234

Authors: G. Nakafero, M. Grainge, A. Valdes, N. Townsend, C. Mallen, W. Zhang, M. Doherty, M. Mamas, A. Abhishek